Xcout IntelSign inSubscribe

IKONISYS

ALIKOHealthtechFrance

Ikonisys is a global provider of automated Fluorescence in Situ Hybridization (FISH) technology, microscopes, software, and reagents for genetic analysis and cancer diagnostics. The company serves laboratories, pathologists, and technicians by offering tools to detect genetic abnormalities, analyze rare cells, and monitor treatment responses.

Subscribe to see IKONISYS’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

IKONISYS at a glance

IKONISYS is a healthtech company headquartered in France. Xcout tracks 1 named person at IKONISYS, including Francesco Trisolini (CEO of Hospitex International).

Industry
Healthtech
Headquarters
France
Ticker
ALIKO

IKONISYS leadership

  • Francesco TrisoliniCEO of Hospitex International

IKONISYS competitors

A few of IKONISYS's closest competitors — see the full list of competitors and alternatives →

Guangzhou LBP Medicine Science & Technology Co., Ltd.688393 · PharmaceuticalsGuangzhou, China
67% matchPublic

Guangzhou LBP Medicine Science & Technology Co., Ltd. specializes in the development and manufacture of innovative pathological diagnostic solutions for the Chinese market. Its comprehensive product portfolio includes advanced pathological diagnostic reagents and essential ancillary equipment. Among these are liquid-based cytology (LBC) offerings, encompassing both gynecological and non-gynecological series, complemented by specialized equipment. The company also provides fluorescence in situ hybridization (FISH) products, which are applied across a broad spectrum of conditions. These applications range from various cancers, including breast, bladder, lung, cervical, prostate, and thyroid, to other complex diagnoses such as neuroblastoma, soft tissue sarcoma, diverse solid tumors, prenatal screening, complications in abortion, oligodendrocytes tumors, lymphoma, multiple myeloma, and several forms of leukemia (chronic myelogenous, chronic lymphocytic, acute myeloid, and acute lymphoblastic), as well as myelodysplastic syndromes. Furthermore, GLBP offers immunohistochemistry (IHC) products, comprising a range of antibodies, advanced detection and repair systems, complementary products, and complete IHC kits. Additionally, its capabilities extend to molecular genetic diagnosis products. Established in 2005, Guangzhou LBP Medicine Science & Technology Co., Ltd. is headquartered in Guangzhou, China.

Market cap$281.3M
Employees768
Guangzhou LBP Medicine Science & Technology Co., Ltd. competitors & alternatives →

Get IKONISYS's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Something wrong or missing about IKONISYS? Suggest a correction

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

IKONISYS — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on IKONISYS in Xcout Intel

  • 1 named person with titles, LinkedIn and board committees
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →